Back to Search
Start Over
Interrelations between the maturation of a 100 kDa nucleolar protein and pre rRNA synthesis in CHO cells.
- Source :
-
Nucleic acids research [Nucleic Acids Res] 1984 Apr 11; Vol. 12 (7), pp. 3025-35. - Publication Year :
- 1984
-
Abstract
- The synthesis of preribosomal RNA is inhibited "in vivo" and "in vitro" by the protease inhibitor leupeptin. "In vivo" leupeptin decreases by 74% the incorporation of labeled uridine into 45S pre rRNA while the synthesis of other RNA species is only slightly decreased. "In vitro", the elongation of already initiated pre rRNA chains that is achieved by incubation of isolated nucleoli is blocked by leupeptin. On the other hand, "in vitro" leupeptin has no direct effect on RNA polymerase I, tested in a nonspecific transcriptional system with Calf thymus DNA as template and in run off experiments with a cloned DNA containing the initiation site of the rDNA gene. A 100 kDa nucleolar protein which has been shown to be endoproteolytic cleaved "in vivo" (1) acts as an inhibitor of rDNA transcription in presence of leupeptin but produces little effect on the nonspecific transcription. In absence of the drug, the 100 kDa protein is processed in specific peptides which appeared to be similar to the "in vivo" maturation products. The possible role of the 100 kDa maturation process in the regulation of rDNA transcription is discussed.
- Subjects :
- Animals
Cell Line
Cell Nucleolus drug effects
Cloning, Molecular
Cricetinae
Cricetulus
DNA genetics
DNA, Ribosomal
Female
Molecular Weight
Ovary
Plasmids
RNA Precursors
Cell Nucleolus metabolism
Leupeptins pharmacology
Nucleic Acid Precursors genetics
Nucleoproteins metabolism
Oligopeptides pharmacology
RNA, Ribosomal genetics
Transcription, Genetic drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 0305-1048
- Volume :
- 12
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Nucleic acids research
- Publication Type :
- Academic Journal
- Accession number :
- 6562463
- Full Text :
- https://doi.org/10.1093/nar/12.7.3025